Application of Ex-Vivo/3D Organoid Models in COVID-19 Research
IntechOpen eBooks2021
Citations Over Time
Abstract
COVID-19 treatment methods based on 3D organoids and ex-vivo platforms are analyzed in this chapter. Initially, the platforms available for cell culture and its working characteristics are explained. Subsequently discusses the organoids with their definition and included their uses in various applications. Further, the chapter extends to describe the uses of different organoids with their use in different stages. Most of these methods utilized the 3D ex-vivo cell culture method to develop organoids and test them over infected tissues. Based on the study in this chapter, it is found that the demonstration of active replication of the human organoids culture system of lungs is found to be more helpful for COVID-19 treatment.
Related Papers
- → Engineered materials for organoid systems(2019)394 cited
- → Development of a miniaturized 3D organoid culture platform for ultra-high-throughput screening(2020)112 cited
- → 3D bioprinting of colon organoids in ultrashort self-assembling and decorated peptide matrices(2024)6 cited
- → Chemosensitivity of 3D Pancreatic Cancer Organoids Is Not Affected by Transformation to 2D Culture or Switch to Physiological Culture Medium(2022)7 cited
- → Application of Ex-Vivo/3D Organoid Models in COVID-19 Research(2021)1 cited